MSF Charity Secures Generic Hepatitis C Drugs for $1.40 a Day
MSF said the deals with generic companies meant it was now able to provide a 12-week course of treatment for around $120, against $1,400 to $1,800 available through Gilead and BMS access programs for poorer nations.